THROMBOPROPHYLAXIS
Clinical trials for THROMBOPROPHYLAXIS explained in plain language.
Never miss a new study
Get alerted when new THROMBOPROPHYLAXIS trials appear
Sign up with your email to follow new studies for THROMBOPROPHYLAXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a simple pill prevent deadly clots in lung cancer patients?
Prevention Not yet recruitingThis study tests whether the blood thinner apixaban can prevent dangerous blood clots in people with lung cancer who are receiving chemotherapy or similar treatments. About 1,456 participants will take either apixaban or a placebo twice a day for six months. The goal is to see if…
Matched conditions: THROMBOPROPHYLAXIS
Phase: PHASE3 • Sponsor: University of Birmingham • Aim: Prevention
Last updated Jun 26, 2026 14:52 UTC
-
ICU kidney patients: do blood thinners need a new recipe?
Knowledge-focused Not yet recruitingThis study looks at how the blood thinner enoxaparin works in critically ill ICU patients with kidney failure, some on dialysis and some not. Researchers will measure drug levels in the blood over 24 hours after a daily shot. The goal is to see if current dosing is enough to prev…
Matched conditions: THROMBOPROPHYLAXIS
Phase: NA • Sponsor: Clinique Saint Pierre Ottignies • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC